Ossiam’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.05M Sell
4,600
-66,608
-94% -$29.7M 0.02% 267
2025
Q1
$34.5M Buy
71,208
+6,375
+10% +$3.09M 0.48% 43
2024
Q4
$26.1M Buy
64,833
+435
+0.7% +$175K 0.45% 43
2024
Q3
$30M Sell
64,398
-1,107
-2% -$515K 0.58% 40
2024
Q2
$30.7M Buy
65,505
+54,411
+490% +$25.5M 0.58% 43
2024
Q1
$4.64M Buy
11,094
+2,100
+23% +$878K 0.08% 148
2023
Q4
$3.66M Buy
8,994
+1,238
+16% +$504K 0.06% 145
2023
Q3
$2.7M Buy
7,756
+227
+3% +$78.9K 0.05% 170
2023
Q2
$2.65M Sell
7,529
-91,574
-92% -$32.2M 0.05% 182
2023
Q1
$31.2M Buy
99,103
+3,044
+3% +$959K 0.65% 41
2022
Q4
$27.7M Buy
96,059
+1,765
+2% +$510K 0.72% 41
2022
Q3
$27.3M Sell
94,294
-1,764
-2% -$511K 0.79% 29
2022
Q2
$27.1M Buy
96,058
+1,984
+2% +$559K 0.81% 35
2022
Q1
$24.6M Buy
94,074
+4,020
+4% +$1.05M 0.64% 37
2021
Q4
$19.8M Buy
90,054
+87,369
+3,254% +$19.2M 0.52% 51
2021
Q3
$487K Buy
2,685
+393
+17% +$71.3K 0.01% 315
2021
Q2
$462K Sell
2,292
-2,676
-54% -$539K 0.01% 326
2021
Q1
$1.07M Buy
4,968
+4,711
+1,833% +$1.01M 0.03% 212
2020
Q4
$61K Buy
257
+205
+394% +$48.7K ﹤0.01% 378
2020
Q3
$14K Sell
52
-2
-4% -$538 ﹤0.01% 379
2020
Q2
$16K Sell
54
-3,357
-98% -$995K ﹤0.01% 412
2020
Q1
$812K Buy
3,411
+2,858
+517% +$680K 0.06% 185
2019
Q4
$121K Sell
553
-347
-39% -$75.9K 0.01% 367
2019
Q3
$152K Buy
900
+590
+190% +$99.6K 0.01% 346
2019
Q2
$57K Sell
310
-17,472
-98% -$3.21M ﹤0.01% 409
2019
Q1
$3.27M Sell
17,782
-9,563
-35% -$1.76M 0.27% 77
2018
Q4
$4.53M Buy
+27,345
New +$4.53M 0.68% 44